JAMMI Canada Journal

Official Twitter account for The Journal of the Association of Medical Microbiology and Infectious Disease Canada

[JAMMI Canada Journal @JAMMI_Journal]

Now available through JAMMI #AdvanceAccess: a new article examining Vagococcus fluvialis as an emerging cause of infective endocarditis and whether its presence in blood cultures should raise clinical suspicion. Discover the findings: https://t.co/9JaaIqPq8U @AMMICanada

[JAMMI Canada Journal @JAMMI_Journal]

New #AdvanceAccess research from JAMMI examines the effectiveness of combining daptomycin and linezolid to treat serious Enterococcus bloodstream infections, where standard antibiotics can fall short. Read the full study: https://t.co/rAZaapo45w @UofT_DoM

[JAMMI Canada Journal @JAMMI_Journal]

A new study in JAMMI 11.1 identifies a dangerous strain of Klebsiella pneumoniae that can cause severe infections in healthy adults. Once treatable, it shows resistance to key antibiotics, raising global concern. @WCHRIUofA @LKSIoV @ahs_media
Learn more: https://t.co/7bl05Svsam

[JAMMI Canada Journal @JAMMI_Journal]

New #AdvanceAccess articles from JAMMI are available. Explore how advanced DNA sequencing tools are changing the way infectious diseases are diagnosed and treated, and what this means for real-world clinical outcomes. Learn more: https://t.co/SkbHqC5lvl @med_umontreal

[JAMMI Canada Journal @JAMMI_Journal]

The new issue of the Journal of the Association of Medical Microbiology and Infectious Disease Canada features new studies on how Canadian clinicians diagnose, treat, and prevent Clostridioides difficile infections. Learn more: https://t.co/rau5vadpwd @AMMICanada @McGillMed

[JAMMI Canada Journal @JAMMI_Journal]

A new #AdvanceAccess study in JAMMI examines bacteriophage therapy as a treatment for chronic prosthetic joint infections where surgery and antibiotics have failed. Can phages disrupt biofilms and change outcomes? Explore the findings: https://t.co/5bRSq0V5Eo @CalDomMed

[JAMMI Canada Journal @JAMMI_Journal]

Discover the latest issue of the Journal of the Association of Medical Microbiology and Infectious Disease Canada, featuring research on influenza use for 2025–26, antibiotic prescribing, serious bacterial infections, and more. @AMMICanada
Read more: https://t.co/rau5vadpwd

[JAMMI Canada Journal @JAMMI_Journal]

Read a new #AdvanceAccess article from JAMMI exploring how a decision tree approach can guide implementation of parvovirus B19 and hepatitis A virus nucleic acid testing to qualify plasma for fractionation. Discover key insights: https://t.co/UGeVNOVEAg @CanadasLifeline

[JAMMI Canada Journal @JAMMI_Journal]

A new study in JAMMI 11.1 identifies a dangerous strain of Klebsiella pneumoniae that can cause severe infections in healthy adults. Once treatable, it shows resistance to key antibiotics, raising global concern. @WCHRIUofA @LKSIoV @ahs_media Learn more: https://t.co/7bl05Svsam

[JAMMI Canada Journal @JAMMI_Journal]

The new issue of the Journal of the Association of Medical Microbiology and Infectious Disease Canada features new studies on how Canadian clinicians diagnose, treat, and prevent Clostridioides difficile infections. Learn more: https://t.co/rau5vadpwd @AMMICanada @McGillMed

[JAMMI Canada Journal @JAMMI_Journal]

Discover the latest issue of the Journal of the Association of Medical Microbiology and Infectious Disease Canada, featuring research on influenza use for 2025–26, antibiotic prescribing, serious bacterial infections, and more. Read more: https://t.co/rau5vadpwd @AMMICanada

[JAMMI Canada Journal @JAMMI_Journal]

Discover the latest issue of the Journal of the Association of Medical Microbiology and Infectious Disease Canada. This issue opens with an editorial examining the growing use of emulated trials in #antimicrobial therapy. Read more: https://t.co/if1j8RZRRW @AMMICanada

[JAMMI Canada Journal @JAMMI_Journal]

The new issue of the Journal of the Association of Medical Microbiology and Infectious Disease Canada features new studies on emerging #influenza A(H3N2) variants; dexamethasone treatment for COVID-19 patients; and more. Learn more: https://t.co/if1j8RZRRW @AMMICanada

[JAMMI Canada Journal @JAMMI_Journal]

A new study in JAMMI 10.4 identifies emerging influenza A(H3N2) variants, examines implications for future #vaccine effectiveness, and underscores the need for enhanced molecular and epidemiological surveillance: https://t.co/yjCcZpPGFq @AMMICanada @CDCofBC #MedicalResearch

[JAMMI Canada Journal @JAMMI_Journal]

New research in JAMMI 10.4 explores whether extending dexamethasone treatment beyond 10 days benefits hospitalized #COVID-19 patients who continue to require oxygen. Explore the findings: https://t.co/op8gVACeJm @AMMICanada @UCalgaryFamMed @SchulichMedDent #Microbiology

[JAMMI Canada Journal @JAMMI_Journal]

Read a new article in JAMMI 10.4 evaluating the impact of switching to DOR/3TC/TDF on weight trajectory in patients with significant integrase inhibitor (INSTI)-associated weight gain. Read the study online: https://t.co/gAvkNV9hDv @AMMICanada @UHN #MedicalResearch

[JAMMI Canada Journal @JAMMI_Journal]

JAMMI 10.4 features a new article examining how Canada’s dental care system affects #healthequity, and critically examines the potential benefits, costs, and challenges of the new Canadian Dental Care Plan: https://t.co/5v4PFI5Dkk @AMMICanada @UM_RadyFHS

[JAMMI Canada Journal @JAMMI_Journal]

The new issue of the Journal of the Association of Medical #Microbiology and Infectious Disease Canada (10.4) examines influenza A(H3N2) variants and impacts on future vaccines; Canadian dental care; and more. Read more: https://t.co/if1j8RZRRW @AMMICanada

[JAMMI Canada Journal @JAMMI_Journal]

A new #AdvanceAccess article highlights the emergence of influenza A(H3N2) variants with immune escape potential for 2025–2026. Enhanced surveillance and monitoring are essential.

Read more: https://t.co/832j7gPhq3

@AMMICanada #FluSurveillance #InfectiousDiseases

[JAMMI Canada Journal @JAMMI_Journal]

Seasonal influenza A(H3N2) is evolving with vaccine-mismatched variants expected to predominate in 2025–2026. Discover more: https://t.co/832j7gPhq3 @AMMICanada #PublicHealth #FluResearch #Epidemiology